Our Medical Affairs Team is at Your Service.
We are empowering mental health treatment by advancing the science and education of pharmacogenomics. And we’re here to help you help your patients.
Superior Customer Support
In a survey conducted between July 31, 2023 to December 8, 2023, 98% of GeneSight-prescribing clinicians surveyed were satisfied or very satisfied with their interaction with the Medical Affairs team, specifically in the areas of:
Professionalism: 100%
Knowledge: 96%
Clear Communication: 98%
Understanding Your Needs: 94%
Your Partner in Pharmacogenomics
The Medical Affairs team consists of highly-educated experts with advanced degrees who serve as a clinical and scientific resource for healthcare providers like you. Our team is available to deliver complimentary report consultations on the interpretation of specific GeneSight reports, provide evidence-based education to increase awareness and knowledge of PGx testing, direct you to evidence-based clinical resources, and more.
Our Medical Affairs team members are leading contributors in the precision medicine space
The team collaborates with clinicians and researchers on potential investigator-initiated clinical trials, and gathers feedback on the GeneSight Psychotropic test through two-way scientific exchange with stakeholders and clinicians.
When scheduling your free consultation please include your name, NPI, and any specific questions you have.
Meet the Team
Leadership
The Myriad Medical Affairs leadership is responsible for providing scientific and clinical support for GeneSight to stakeholders and practitioners in the healthcare ecosystem.
Dr. Holly Johnson
PhD in Neuroscience
Director of Medical Affairs
Dr. Johnson oversees medical strategy development and execution, evidence generation, and medical content creation to advance the science and education of psychiatric pharmacogenomics.
Dr. Rachael Hart Earls
PhD in Molecular Neuroscience
Medical Science Liaison Manager
Dr. Earls helps support pharmacogenomic education efforts, medical strategy, and evidence generation to advance the science of psychiatric pharmacogenomics.
Medical Science Liaisons
Medical Science Liaisons (MSLs) are field-based members of the medical affairs team that cover distinct geographies across the United States. The MSL team provides in-person educational support on pharmacogenomics to healthcare providers.
Dr. Ryan Griggs
PhD in Neurophysiology
Senior Medical Science Liaison
Dr. Ryan Griggs supports Ohio, Indiana, and Michigan and strives to improve mental health care by supporting psychiatric pharmacogenomic testing.
Dr. Samantha Socco
PharmD
Senior Medical Science Liaison
Dr. Samantha Socco supports the midwestern region of the United States (Illinois, Iowa, Kansas, Minnesota, Missouri, North Dakota, Oklahoma, and Wisconsin). Dr. Socco has specialized residency training in clinical pharmacy and pharmacogenomics and has a strong interest in pharmacogenomics implementation and the advancement of pharmacogenomics in psychiatric care.
Dr. Nick Haynes
PhD in Neuroscience & Psychology
Medical Science Liaison
Dr. Nick Haynes supports the northwestern region of the United States (Colorado, California, Idaho, Montana, Nevada, South Dakota, Utah, and Washington) and aims to understand the mechanisms underlying treating mental health disorders to better manage these illnesses.
Dr. Melissa Dyer
PhD in Neuroscience
Senior Medical Science Liaison
Dr. Melissa Dyer supports the Appalachian region of the United States (Kentucky, Maryland, North Carolina, Tennessee, Virginia, West Virginia, and Washington D.C) and has a strong interest in the application of precision medicine to improve patient outcomes.
Dr. Rachel Montel
PhD in Molecular Bioscience Specializing in Genetics
Medical Science Liaison
Dr. Rachel Montel supports the northeast region of the United States (New York, New Jersey, Connecticut, Pennsylvania, Vermont, New Hampshire, Massachusetts, and Maine) and is currently focused on helping providers understand how pharmacogenomics can better serve their practice.
Dr. Asti Jackson
PhD in Behavioral Pharmacology
Medical Science Liaison
Dr. Asti Jackson supports the southeastern region of the United States (Georgia, Florida, Alabama, South Carolina, Tennessee, and Louisiana). A former Assistant Professor in the department of Psychiatry at Yale, Dr. Jackson aims to help improve the lives of those suffering from mental health conditions by supporting the utility of psychiatric pharmacogenomic testing.
Dr. Morgan Freas
PharmD
Executive Medical Science Liaison
Dr. Morgan Freas supports the southwestern region of the United States (Arkansas, Missouri, Arizona, California, New Mexico, and Texas) and has a robust interest in advancing pharmacist involvement in pharmacogenomic testing through medication management.
Medical Information Liaisons
Medical information liaisons (MILs) are headquarter-based members of the medical affairs team that are on-call Monday-Friday 8:00 am-6:00 pm EST. MILs can answer any inquiries related to mental health or pharmacogenomics for healthcare providers or patients and create educational collateral to increase awareness and knowledge of pharmacogenomic testing.
Dr. Kale Hanavan
PharmD
Senior Medical Information Liaison
Dr. Hanavan is a licensed clinical pharmacist and has a keen interest in integrating evidence-based medicine with business strategy to stimulate innovation in patient care.
Priya Maheshwari
Registered Pharmacist
Senior Medical Information Liaison
Priya Maheshwari is a licensed pharmacist registered across three states with over 12 years of experience in both retail and behavioral health pharmacy practice. She is a strong advocate for the integration of pharmacogenomics into clinical practice through Medication Therapy Management (MTM), driving toward the frontier of personalized medicine.
Dr. Gautham Kartha
MD
Senior Medical Information Liaison
Dr. Kartha is a medical doctor and supports the use of evidence-based tools to improve the clinical care of individuals with psychiatric conditions. He strongly believes that providing high-quality education about pharmacogenomics will help to reduce the burden of the ongoing mental health crisis.
Dr. Richard Brunner
PharmD
Senior Medical Information Liaison
Dr. Brunner is a licensed clinical pharmacist and holds a Pharmacogenomic certification through University of Colorado Skaggs School of Pharmacy. Dr. Brunner has a strong interest in advancing the field of psychiatric pharmacogenomics.
Dr. Renee Albers
PhD in Biomedical Sciences
Senior Medical Information Liaison
Dr. Albers has a strong interest in genetics research and how genetic information can be used to help those with mental health conditions.